Amphastar Pharmaceuticals, Inc.
AMPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,238,532 | $1,077,949 | $1,381,113 | $1,798,169 |
| - Cash | $216,500 | $187,689 | $182,782 | $151,609 |
| + Debt | $656,773 | $655,497 | $652,533 | $650,549 |
| Enterprise Value | $1,678,805 | $1,545,757 | $1,850,864 | $2,297,109 |
| Revenue | $191,840 | $174,414 | $170,528 | $186,523 |
| % Growth | 10% | 2.3% | -8.6% | – |
| Gross Profit | $98,646 | $86,490 | $85,251 | $86,648 |
| % Margin | 51.4% | 49.6% | 50% | 46.5% |
| EBITDA | $41,926 | $61,855 | $52,355 | $65,051 |
| % Margin | 21.9% | 35.5% | 30.7% | 34.9% |
| Net Income | $17,350 | $31,030 | $25,285 | $37,964 |
| % Margin | 9% | 17.8% | 14.8% | 20.4% |
| EPS Diluted | 0.37 | 0.64 | 0.51 | 0.74 |
| % Growth | -42.2% | 25.5% | -31.1% | – |
| Operating Cash Flow | $52,583 | $35,592 | $35,077 | $29,024 |
| Capital Expenditures | -$5,348 | -$10,565 | -$10,697 | -$12,411 |
| Free Cash Flow | $47,235 | $25,027 | $24,380 | $16,613 |